MORF
Morphic Holding Inc
Halal Rating :
Last Price
$56.99
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Morphic Holding Inc is a biopharmaceutical company focused on developing oral small-molecule integrin therapeutics. The company is developing treatments for autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Their lead product candidate, MORF-057, is being developed for the treatment of inflammatory bowel disease.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Morphic Holding Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.